Jove
Visualize
Contact Us

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

329
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
329
Actuarial Approach01:20

Actuarial Approach

63
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
63
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
  1. Home
  3. Survival And Recurrence Rates Following Sbrt Or Surgery In Medically Operable Stage I Nsclc.
  1. Home
  3. Survival And Recurrence Rates Following Sbrt Or Surgery In Medically Operable Stage I Nsclc.

Related Experiment Video

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.4K

Survival and recurrence rates following SBRT or surgery in medically operable Stage I NSCLC.

Michael Snider1, Joseph K Salama2, Matthew Boyer2

  • 1Department of Radiation Oncology, Duke University School of Medicine, Durham, NC, United States.

Lung Cancer (Amsterdam, Netherlands)
|October 4, 2024

View abstract on PubMed

Summary
This summary is machine-generated.

For medically operable Stage I non-small cell lung cancer (NSCLC), surgery (lobectomy or sub-lobar resection) offers superior survival outcomes compared to stereotactic body radiation therapy (SBRT). SBRT was associated with higher regional recurrence rates.

Keywords:
Early stage NSCLCLobectomySBRTSub-lobar resectionSurgical candidates

More Related Videos

Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

18.1K
Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

14.2K

Related Experiment Videos

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.4K
Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

18.1K
Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

14.2K

Area of Science:

  • Thoracic Surgery
  • Radiation Oncology
  • Pulmonary Medicine

Background:

  • Surgery is the standard treatment for early-stage non-small cell lung cancer (NSCLC).
  • Stereotactic body radiation therapy (SBRT) is typically reserved for patients unsuitable for surgery.
  • The Veterans' Health Care System (VAHS) database was used to compare outcomes.

Purpose of the Study:

  • To compare overall survival (OS), lung cancer-specific survival (LCSS), progression-free survival (PFS), and recurrence rates.
  • To evaluate SBRT versus surgical resection (lobectomy and sub-lobar resection) in medically operable Stage I NSCLC patients.
  • To determine if current criteria for operability adequately select patients for SBRT.

Main Methods:

  • A retrospective study of medically operable Stage I NSCLC patients (FEV1/DLCO >60%, Charlson Comorbidity Index 0-1) from 2000-2020 in the VAHS.
  • Propensity score matching created 1:1:1 cohorts for SBRT, lobectomy, and sub-lobar resection.
  • Outcomes including OS, LCSS, PFS, and recurrence patterns were analyzed.

    • Main Results:

    • 103 patients per group were analyzed with a median follow-up of 7.9 years.
    • SBRT was associated with significantly worse OS, LCSS, and PFS compared to both lobectomy and sub-lobar resection.
    • Higher regional recurrence rates were observed with SBRT (15.5%) versus lobectomy (6.8%) or sub-lobar resection (4.9%).

    Conclusions:

    • Lobectomy and sub-lobar resection demonstrated superior OS, LCSS, and PFS over SBRT for medically operable Stage I NSCLC.
    • Higher regional recurrence rates after SBRT may contribute to poorer survival outcomes.
    • Pulmonary function and comorbidity indices alone are insufficient for selecting patients for SBRT, suggesting a need for strategies to mitigate regional recurrence.